Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Author(s):
Rajiv Rampat
,
David Hildick-Smith
Added:
3 years ago
Left main stem (LMS) disease is identified in up to 5 % of diagnostic angiography cases.1 It has major prognostic significance due to the proportion of myocardium at risk. Many years ago, the Coronary Artery Surgery Study (CASS) registry demonstrated the superiority of coronary artery bypass grafting (CABG) over medical therapy with a 5-year mortality reduction from 43 % to 16 % in symptomatic…
View more
Author(s):
Jonathan A Mailey
,
Patrick Thompson
,
Paul W Johnston
,
et al
Added:
1 year ago
Author(s):
David Hildick-Smith
Added:
11 months ago
EuroPCR 23 - Join us as we discover the latest findings from a three-year follow-up of the EBC MAIN Trial, as we interview Principal Investigator Dr David Hildick-Smith (Brighton and Sussex University Hospitals, UK) onsite at EuroPCR 23.
The EBC Main Trial aimed to investigate the outcomes of single-stent versus dual-stent bifurcation treatment of distal left main coronary artery lesions. This…
View more
Foreword
Author(s):
Simon Kennon
Added:
3 years ago
Article
Editorial
Author(s):
Angela Hoye
Added:
3 years ago
Article
Foreword
Author(s):
Simon Kennon
Added:
3 years ago
Article
Foreword
Author(s):
Simon Kennon
Added:
3 years ago
Article
Foreword
Author(s):
Simon Kennon
Added:
3 years ago
Article
Author(s):
Giovanni Luigi De Maria
,
Adrian P Banning
Added:
3 years ago
Detection of obstructive disease of the left main coronary artery (LMCA) is relatively unusual in the catheterisation laboratory, as it accounts for approximately 4 % of all coronary angiograms, with isolated LMCA disease observed in only 5–10 % of these cases.1
Intervention to the LMCA is, however, notable compared to the treatment of coronary stenosis elsewhere in the coronary tree. First,…
View more